approved EB-2 (NIW)

Nephrologist

Nephrology · Pakistan · 2023-11-30

Processing Time
2 days
Decision Date
2023-11-30
Location
Kentucky
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop strategies for early drug toxicity recognition, treatment implementation, and the use of novel therapies for chronic, rare, and evolving kidney diseases. This work aims to improve healthcare outcomes for high-risk patient populations and advance global knowledge in the field of nephrology.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses chronic and rare kidney diseases, aiming to improve U.S. population health and reduce economic burdens on the healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her advanced medical degree, extensive publication record in top venues, and 13 completed peer reviews.

3 Waiver Benefit Met

On balance, her proactive approaches to kidney disease management benefit the U.S. by easing the strain on the healthcare sector and taxpayers.

Why This Petition Was Approved

The case was approved based on the petitioner's M.B.B.S. degree, 15 peer-reviewed journal articles (8 first-authored), 1 first-authored book chapter, and 51 citations. Additionally, she completed 13 peer reviews and provided expert testimonials affirming her alignment with U.S. national interests.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions
Judging Experience
Government Alignment

Similar Cases

Research Scientist

Healthcare · India

WeGreened EB-2 (NIW) approved
Massachusetts 20 days 2025-06-05
The petitioner proposes to advance the development of quantitative clinical decision-making tools to enable earlier and more precise interventions for chronic, life-altering diseases. Her work focuses on applying advanced epidemiological and statistical methods to create early detection protocols and personalized treatment strategies. The endeavor aims to improve patient outcomes in high-risk populations while reducing the economic burden of long-term disease management.

Physician

Healthcare · Dominican Republic

WeGreened EB-2 (NIW) approved
New York 104 days 2022-10-28
The petitioner proposes to continue her research on improving the management and implementation of care for patients with chronic kidney disease and related conditions. Her work focuses on the pathogenesis of kidney disease, specifically in the context of complement-mediated pregnancy disorders and infectious diseases like COVID-19, to improve health outcomes and reduce healthcare expenditures.

Director

Healthcare · South Korea

WeGreened EB-2 (NIW) approved
California 7 days 2024-01-05
The petitioner proposes to conduct epidemiological studies focusing on individuals at risk for kidney and cardiovascular diseases to improve patient health outcomes. Her work involves clarifying the epidemiological terrain and providing actionable insights to advance global health policies and medical treatments.

Clinical Researcher

Healthcare · Thailand

WeGreened EB-2 (NIW) approved
Massachusetts 55 days 2025-05-19
The petitioner proposes to improve clinical outcomes for patients with chronic kidney disease (CKD) by expanding equitable access to kidney transplantation and enhancing the adoption of home dialysis therapies. His work involves leveraging artificial intelligence, machine learning, and donor-derived cell-free DNA (dd-cfDNA) to optimize transplant monitoring and early diagnosis strategies.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-11-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 2 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist